Create Free Account

By creating account you will get access to hot stocks & personalised emails

Capitol Health Ltd

Healthcare AU CAJ

NoneAUD
-(-%)

Last update at 2025-02-27T06:20:47.391071Z

Day Range

--
LowHigh

52 Week Range

0.220.40
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap413.13M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield2.07%
  • EBITDA36.81M
  • Revenue TTM234.82M
  • Revenue Per Share TTM0.22
  • Gross Profit TTM 55.85M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -10.07400M 15.95M 19.44M 2.16M 31.40M
Minority interest -0.12000M -0.23600M 0.29M 0.22M 0.22M
Net income -11.39300M 10.73M 11.92M 0.86M 27.53M
Selling general administrative 141.11M 119.35M 107.00M 96.05M 101.99M
Selling and marketing expenses - - - - -
Gross profit 45.61M 45.80M 46.33M 34.89M 149.14M
Reconciled depreciation 24.75M 21.06M 21.40M 26.02M 8.90M
Ebit 14.42M 20.12M 22.85M 10.05M 12.93M
Ebitda 39.17M 41.18M 44.24M 36.08M 21.83M
Depreciation and amortization 24.75M 21.06M 21.40M 26.02M 8.90M
Non operating income net other - - - - -
Operating income 15.44M 20.07M 20.03M 10.63M 12.93M
Other operating expenses 110.98M 111.28M 107.99M 89.55M 132.11M
Interest expense 3.21M 1.04M 1.41M 3.21M 1.45M
Tax provision 1.20M 4.98M 7.41M 1.07M 3.86M
Interest income 4.14M 1.12M 0.01M 3.39M 1.62M
Net interest income -4.87500M -2.90600M -3.37800M -3.18900M -1.36100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.20M 4.98M 7.41M 1.07M 3.86M
Total revenue 208.50M 184.09M 177.92M 153.61M 149.14M
Total operating expenses 193.85M 163.96M 151.29M 143.46M 132.11M
Cost of revenue 162.88M 138.29M 131.59M 118.72M 112.25M
Total other income expense net -19.84300M -1.26800M -3.80200M -4.48800M 18.46M
Discontinued operations - - - - -
Net income from continuing ops -11.27300M 10.97M 12.03M 1.09M 27.53M
Net income applicable to common shares -11.39300M 10.73M 11.92M 0.86M 24.31M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 319.48M 318.19M 271.19M 279.76M 262.31M
Intangible assets - 16.88M 7.06M 8.26M 8.23M
Earning assets - - - - -
Other current assets 2.05M 2.26M 0.74M 0.79M 0.77M
Total liab 208.82M 180.11M 117.14M 133.73M 118.27M
Total stockholder equity 110.91M 137.09M 153.00M 145.74M 143.82M
Deferred long term liab - - - - -
Other current liab 48.36M 0.70M 30.39M 36.31M 38.22M
Common stock 161.14M 160.16M 153.75M 148.63M 145.78M
Capital stock - 160.16M 153.75M 148.63M 145.78M
Retained earnings -55.00500M -25.77800M -1.79300M -2.99300M -4.65400M
Other liab - 8.30M 12.74M 11.85M 8.38M
Good will 157.11M 157.29M 118.05M 117.78M 109.72M
Other assets 0.00000M 0.22M 5.62M 5.83M 6.37M
Cash 24.05M 19.12M 13.38M 21.75M 13.76M
Cash and equivalents - - - - -
Total current liabilities 70.84M 48.39M 33.54M 37.60M 40.19M
Current deferred revenue 2.04M 27.80M -10.34600M -9.67800M -9.64000M
Net debt 119.91M 115.93M 67.82M 72.32M 65.58M
Short term debt 11.22M 11.62M 10.35M 9.78M 9.64M
Short long term debt - - - - -
Short long term debt total 143.96M 135.05M 81.21M 94.07M 79.34M
Other stockholder equity - -134.38700M -151.95600M -145.63800M -141.12200M
Property plant equipment - 114.38M 101.17M 100.09M 95.55M
Total current assets 31.39M 27.47M 20.11M 28.29M 20.30M
Long term investments - 1.95M 19.18M 19.52M 22.14M
Net tangible assets - -37.08600M 27.89M 19.70M 25.87M
Short term investments 0.14M 0.10M 0.11M 0.17M 0.28M
Net receivables 5.15M 5.99M 4.70M 5.58M 5.49M
Long term debt - 72.80M 19.00M 29.00M 17.00M
Inventory - - 1.18M - -
Accounts payable 9.22M 8.27M 3.15M 1.19M 1.97M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 4.78M 2.71M 1.05M 0.10M 2.69M
Additional paid in capital - - - - -
Common stock total equity - - - - 145.78M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 15.88M -290.51200M 0.29M 0.18M 0.63M
Deferred long term asset charges - - - - -
Non current assets total 288.10M 290.73M 251.08M 251.47M 242.01M
Capital lease obligations - 62.25M 62.21M 65.07M 62.34M
Long term debt total - 123.42M 70.86M 84.28M 69.70M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -62.61800M -14.86800M -21.34400M -32.84500M -50.31500M
Change to liabilities 5.10M -2.21100M -3.36500M 6.34M 0.80M
Total cashflows from investing activities -62.61800M -14.86800M -21.34400M -32.84500M -50.31500M
Net borrowings 41.52M -20.03000M 2.30M -30.03300M 41.67M
Total cash from financing activities 30.81M -26.35700M -11.56100M 4.27M 27.18M
Change to operating activities -2.17100M -4.18200M 0.09M 4.02M 1.16M
Net income -11.39300M 10.73M 11.92M 0.86M 27.53M
Change in cash 5.73M -8.36500M 7.99M 6.43M -4.80700M
Begin period cash flow 13.38M 21.75M 13.76M 7.33M 12.14M
End period cash flow 19.12M 13.38M 21.75M 13.76M 7.33M
Total cash from operating activities 37.54M 31.86M 40.89M 35.01M 18.33M
Issuance of capital stock - 4.27M 0.39M 38.50M 1.78M
Depreciation 24.32M 20.62M 21.40M 20.12M 8.90M
Other cashflows from investing activities -45.77600M -1.00000M -13.70200M -20.68000M -35.56800M
Dividends paid -10.71100M -10.59700M -14.25300M -3.84200M 6.61M
Change to inventory - - - - -
Change to account receivables -0.89900M 0.77M -0.08900M -2.83100M 0.99M
Sale purchase of stock 0.00000M 4.27M 0.39M -0.35700M -7.88200M
Other cashflows from financing activities 41.52M -20.03000M 2.30M -8.28300M 76.85M
Change to netincome 22.16M 6.69M 10.94M 6.49M -17.82100M
Capital expenditures 16.84M 13.17M 7.64M 12.16M 14.75M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.89900M 0.77M -0.08900M -2.83100M 0.09M
Stock based compensation 2.42M 1.26M 1.36M 0.72M -
Other non cash items 24.61M 0.51M 7.58M 14.02M -36.43400M
Free cash flow 20.70M 18.69M 33.25M 22.84M -14.74700M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CAJ
Capitol Health Ltd		 - -% - - 16.00 1.76 3.73 2.29 25.06
SHL
Sonic Healthcare Ltd		 0.10 0.38% 26.12 22.37 20.37 1.31 1.50 1.78 9.44
HLS
Healius Ltd		 0.04 2.86% 1.44 - 125.00 0.56 0.98 1.31 10.14
IDX
Integral Diagnostics Ltd		 0.08 3.49% 2.37 113.50 16.16 1.72 1.22 2.74 18.23
ACL
Australian Clinical Labs Ltd		 0.08 2.64% 3.11 20.07 14.24 0.82 3.47 1.22 4.80

Reports Covered

Stock Research & News

View All

Profile

Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy. It operates various clinics in Victoria, Tasmania, Western Australia, and South Australia under the Capital Radiology brand, as well as under the Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens' Imaging, Direct Radiology, and Future Medical Imaging Group brand names. The company was incorporated in 2005 and is headquartered in East Melbourne, Australia. As of December 11, 2024, Capitol Health Limited operates as a subsidiary of Integral Diagnostics Limited.

Capitol Health Ltd

288 Victoria Parade, East Melbourne, VIC, Australia, 3002

  • 61 3 9348 3333
  • Employees : 1000

Key Executives

Name Title Year Born
Mr. Justin Samuel Walter MPH (JCU) CEO, MD & Director NA
Mr. Craig David Bremner Chief Financial Officer NA
Ms. Melanie Jaye Leydin B.Bus, C.A., CA Company Sec. 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary 1973

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

Market Research
ISO Certified pcidss

Kalkine Solutions Private Limited, an authorized representative of Kalkine Pty Ltd, holds the ISO 27001:2022 certification (Certificate No. IC-IS-2404072) and the PCI-DSS Version 4.0 Level 1 certification (Certificate No. CSNL1PCI8067).

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2025 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.